BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T070000
DTEND;TZID=Europe/London:20211115T090000
DTSTAMP:20211115T102327Z
CREATED:20210519T193320Z
LAST-MODIFIED:20211115T102327Z
UID:10000046-1636959600-1636966800@www.lgcw.org.uk
SUMMARY:Cancer Control in Gulf Cooperation Council Countries in The Middle East  Hosted by: The Lancet Oncology
DESCRIPTION:Register \nRead this \nCancer Control in Gulf Cooperation Council Countries in The Middle East\nSpeakers: \nDr Ibtihal Fadhil\, Founder and Chair of the Eastern Mediterranean NCD Alliance\, Manama\, Bahrain \nProfessor Samar Alhomoud\, Professor of colorectal surgery and section head at King Faisal Specialist Hospital and Research Center\, Riyadh\, Saudi Arabia \nDr Shahrukh K Hashmi\, Sheikh Shakhbout Medical City\, Abu Dhabi\, UAE \nDr Mohammed Hamad J T Al-Thani\, Director of Public Health Department\, Ministry of Public Health\, Qatar
URL:https://www.lgcw.org.uk/event/cancer-control-in-gcc-countries-in-the-middle-east-hosted-by-the-lancet-oncology/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2020/06/TLO.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T090000
DTEND;TZID=Europe/London:20211115T103000
DTSTAMP:20211031T114254Z
CREATED:20210519T193320Z
LAST-MODIFIED:20211031T114254Z
UID:10000047-1636966800-1636972200@www.lgcw.org.uk
SUMMARY:Population-based Cancer Registration in sub-Saharan Africa  Hosted by: African Cancer Registry Network
DESCRIPTION:Register \nPopulation-based cancer registration in sub-Saharan Africa (1 hour 30 minutes)\nModerators: Naomi Oyoe Ohene Oti\, Eric Chokunonga\n\nThe African Cancer Registry Network  (Eric Chokunonga\, Manager\,  Zimbabwe National Cancer Registry\, Zimbabse)\nTrends in the incidence of the major cancers in sub Saharan Africa (Elima Jedy-Agba\, senior researcher\,  International Research Center of Excellence\, Institute of Human Virology\, Nigeria)\nSurvival from cancer in sub Saharan Africa (Yvonne Joko\, Research Fellow\, International Agency for Research on Cancer)\nThe Southern Africa Childhood Cancer Registry (Natasha Abraham\, epidemiologist\, National Cancer Registry\, South Africa)\nCreating a national cancer registry network – the Tanzania experience (Gisbert Mswiga\, Consultant\, Vital Strategies\, Tanzania)\nStaging with Essential TNM in African registries (Biying Liu\, Researcher\, African Cancer Registry Network\, Oxford)
URL:https://www.lgcw.org.uk/event/population-based-cancer-registration-in-sub-saharan-africa-hosted-by-african-cancer-registry-network/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/AFCRN-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T103000
DTEND;TZID=Europe/London:20211115T113000
DTSTAMP:20211026T082201Z
CREATED:20210519T193320Z
LAST-MODIFIED:20211026T082201Z
UID:10000048-1636972200-1636975800@www.lgcw.org.uk
SUMMARY:Nuclear Applications in Human Health for Effective Global Cancer Control – The Role of the IAEA  Hosted by: International Atomic Energy Agency (IAEA/NAHU)
DESCRIPTION:Register – IAEA (10:30 – 11:30) \nRegister – WHO (11:30 – 3:30 – GMT) \nNuclear Applications in Human Health for Effective Global Cancer Control – The Role of the IAEA\nDownload programme \n\n\n\nTime (GMT)\nTopic\nFacilitators\n\n\n\n\n\n\n\n\n\n10.30 – 11.30\nUN Agency Highlight: nuclear applications in Human Health for effective global cancer control – The role of the IAEA   \n\n\n10.30 – 10:32\nWelcome and introduction\nIAEA/NAHU/Dir: May Abdel-Wahab \nModerator: SH ARBR/  \nKatie Wakeham\n\n\n10.32 – 10:42\nFrom prevention to palliation: advising Member States in the use of nuclear techniques in cancer control\nIAEA/NAHU/ ARBR:  Kirsten Hopkins\n\n\n10.42 – 10:50\nRole of nuclear nutrition techniques in supporting cancer prevention and care\nIAEA/NAHU/ SH NAHRES: Cornelia Loechl\n\n\n10.58 – 11:06\nIAEA global initiatives in imaging and nuclear medicine\nIAEA/NAHU/SH NMDI: Diana Paez\n\n\n10.50 – 10:58\nScaling-up radiotherapy in cancer control \nIAEA/NAHU/ ARBR:  Alfredo Polo\n\n\n11.06 – 11.14\nTranslating research into technical cooperation\nIAEA/NAHU/ NMDI: Francesco Giammarile\n\n\n11.14 – 11.22\nIn-country implementation activities and programmes\nIAEA/TCAF-Division for Africa/ \nDir: Shaukat Abdulrazak\n\n\n11.22 – 11.25\nQ&A\nGroup\n\n\n11.25 – 11.30\nBrief Break – Click below to register for the WHO event – straight after the break.\n\n\n\n  \nRegister for our back to back event with the WHO >>  \nIAEA – International Atomic Energy Agency (@iaeaorg) / Twitter \nIAEA NA (@IAEANA) / Twitter
URL:https://www.lgcw.org.uk/event/international-atomic-energy-agency-iaea-nahu-special-programmes-hosted-by-international-atomic-energy-agency-iaea-nahu/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/IAEA-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T113000
DTEND;TZID=Europe/London:20211115T153000
DTSTAMP:20211115T102916Z
CREATED:20210519T193321Z
LAST-MODIFIED:20211115T102916Z
UID:10000049-1636975800-1636990200@www.lgcw.org.uk
SUMMARY:World Health Organisation\, International Agency for Research on Cancer and International Atomic Energy Agency  Hosted by: World Health Organisation\, International Agency for Research on Cancer and International Atomic Energy Agency
DESCRIPTION:Register – WHO (11:30 – 3:30 – GMT) \nRegister – IAEA (10:30 – 11:30 – GMT) \nWorld Health Organisation\, International Agency for Research on Cancer and International Atomic Energy Agency\n << See programme for our joint event with IAEA @10:30 \nBackground\nLondon Global Cancer Week\, scheduled for 14 – 19 November\, will convene leading global cancer organizations and public health agencies to review the global state of cancer\, to share best practices and to set the global agenda towards the theme “Shining a light on the global cancer epidemic” The event will be predominantly online events\, offering an opportunity for an increased size and diversity of the audience. \nThe objective of the World Health Organization (WHO)\, the International Agency for Research on Cancer (IARC) and the International Atomic Energy Agency (IAEA) participation in this global forum is (I) to engage the broad\, multi-sectoral participants\, (II) provide a platform for information exchange and best practices\, and (III) to share progress and reflect about the UN activities at the country-level action. \nWHO organized a joint UN Agency presentation consisting of four sessions on Nov 15th\, from 11:30h to 15:30h United Kingdom time. The session themes are: (I) Cancer control today: are we on track to achieve SDGs? (II) Effective Cancer Control Planning: Addressing the gaps (III) UN Programmes to Accelerate Implementation (IV) Implementation Research to Guide Program Scale-Up. Immediately prior to this joint session\, the IAEA-NAHU team will have a special spotlight session from 10:30h – 11:30h UK time highlighting there several cancer related activities. \nThe broad multi-sectoral audience will include content experts\, leaders in the scientific community\, media outlets\, among many others.  Notable participant organizations and institutions include: The Commonwealth Secretariat\, National Cancer Grid India\, NCI Centre for Global Health\, Royal Institute of International Affairs Chatham House\, and the Royal College of Surgeons of England\, Royal Society of Nurses\, African Cancer Registry Network\, the Institute of Cancer Policy\, King’s College London. \nSession Goals\nThe overall session objectives are to: \n\ninform participants of activities from UN agencies (WHO\, IARC and IAEA) in cancer control including recent advancements in WHO global initiatives and collaboration efforts under the framework of the WHO-IAEA Joint Program on Cancer Control\noffer unique opportunity to engage with leadership from the three agencies\, to ask questions and to better understand the strategic direction of UN agencies in cancer\ninform and discuss progress about the WHO Global Initiatives (Breast\, Cervical\, Childhood Cancer)\, and the cross-cutting platforms that support National Cancer Control Programmes\nshare partnership experiences among UN agencies\, partners\, and member states\ndiscuss implementation research opportunities to support tailored cancer care interventions\n\nThe sessions are designed to maximize audience participation and to present novel approaches to cancer control. To facilitate participation\, there will be time allocated to question and answer from the audience. The sessions will be moderated to enable a dynamic discussion. Consideration will be made for use of interactive approaches like the use of polls to stimulate audience participation. \n  \n  \n\n\n\n11.30 – 12.30\nJoint Session #1: Cancer control today: are we on track to achieve SDGs?\n\n\n\n\n11.30 – 11.35\nWelcome and Introductions\n\n\n\n\n\nFacilitator: André Ilbawi\, WHO \n\n\n\n\n\n\n\n11.35 – 11.45\n\n\n\n\n\nEmpowering countries through multi-sectoral partnerships \n\n\n\n\n\n\n\n\n\n\nDr. Janaki Vidanapathirana\, Ministry of \nHealth\, Sri-Lanka \n\n\n\n\n\n\n\n\n\n\n\n\n11.45 –11.55 \n\n\n\n\n\n\n\n\n\n\nFraming priorities to subsidize planning and investment \n\n\n\n\n\n\n\n\n\n\nDr. Arman Kacharian\, Ministry of Health\, Ukraine \n\n\n\n\n\n\n\n\n\n\n\n\n11.55 – 12.10 \n\n\n\n\n\n\n\n\n\n\nRoundtable 1: Cancer control in 2030: what is success and how do we get there? \n\n\n\n\n\n\n\n\n\n\nModerator: Diana Rubin (PACT)\nPanelist: Bente Mikkelsen (WHO NCDs Director)\, Elisabete Weiderpass (IARC Director)\, Lisa Stevens (IAEA PACT Director)\, May Abdel-Wahab (IAEA NAHU Director) \n\n\n\n\n\n\n\n12.10 – 12.20\n\n\n\n\n\nIARC Mid-term strategy to reduce global cancer burden: cancer research that matters \n\n\n\n\n\n\n\n\n\n\nElisabete Weiderpass\, IARC Director \n\n\n\n\n\n\n\n12.20 – 12.25\nQ&A\n\n\n\n\n\nGroup\, facilitator guided \n\n\n\n\n\n\n\n12.25 – 12.30\nBrief Break\n\n\n\n  \n\n\n\n12.30 – 13.40\nJoint Session #2: Effective Cancer Control Planning: Addressing the gaps\n\n\n\n\n12.30 – 12.32\n\n\n\n\n\nSession introduction \n\n\n\n\n\n\n\n\n\n\nFacilitator: Vitaly Smelov\, WHO EURO \n\n\n\n\n\n\n\n12.32 – 12.42\n\n\n\n\n\nInvesting in systems to improve cancer control \n\n\n\n\n\n\n\n\n\n\nCesaltina Lorenzoni\, Ministry of Health\, Mozambique \n\n\n\n\n\n\n\n\n\n\n\n\n12.42 – 12.47 \n\n\n\n\n\n\n\n\n\n\nCancer screening programmes in Kazakhstan: experience through international collaboration \n\n\n\n\n\n\n\n\n\n\nDilyara Kaidarova\, National cancer center KazIOR\, Head \n\n\n\n\n\n\n\n12.47 – 12.55\n\n\n\n\n\nUzbekistan: NCCP supported by international partnership \n\n\n\n\n\n\n\n\n\n\nDilshod Egamberdiev and Nargiza Zakirova\, NCC/IsDB Uzbekistan Leading Oncologists \n\n\n\n\n\n\n\n12.55 – 13.05\n\n\n\n\n\nNational Cancer Control Plans: case study \n\n\n\n\n\n\n\n\n\n\nYannick Romero – ICCP \n\n\n\n\n\n\n\n13.05 – 13.15\n\n\n\n\n\nFinancing cancer control: source and platforms \n\n\n\n\n\n\n\n\n\n\nCindy Kremer – IAEA \n\n\n\n\n\n\n\n13.15 – 13.30\n\n\n\n\n\n\n\n\n\nRoundtable 2: Operationalizing Cancer Control based on Evidence-Based Plan Development \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator: Geraldine Arias de Goebl\, (IAEA) Panelists: Cesaltina Lorenzoni (Ministry of Health\, Mozambique)\, Yannick Romero (ICCP)\, Cindy Kremer (IAEA) \n\n\n\n\n\n\n\n\n\n\n\n13.30 – 13.35\nBrief Break\n\n\n\n  \n\n\n\n13.35 – 14.45\nJoint Session #3: UN PROGRAMMES TO ACCELERATE IMPLEMENTATION \n\n\n\n\n13.35 – 13.38\nSession introduction\n\n\n\n\n\nFacilitator: Elena Fidarova\, WHO \n\n\n\n\n\n\n\n13.38 – 13.48\n\n\n\n\n\nWHO Global Initiative for Childhood Cancer (GICC) \n\n\n\n\n\n\n\n\n\n\nRoberta Ortiz\, WHO \n\n\n\n\n\n\n\n13.48 – 13.58\n\n\n\n\n\nWHO Cervical Cancer Elimination Initiative (CCEI) \n\n\n\n\n\n\n\n\n\n\nPrincess Nothemba (Nono) Simelela\, WHO \n\n\n\n\n\n\n\n13.58 – 14.08\n\n\n\n\n\nWHO Global Breast Cancer Initiative (GBCI) \n\n\n\n\n\n\n\n\n\n\nBen Anderson\, WHO \n\n\n\n\n\n\n\n14.08 – 14.18\n\n\n\n\n\nIARC scientific evidence to inform WHO Global Initiatives \n\n\n\n\n\n\n\n\n\n\nFreddie Bray\, IARC \n\n\n\n\n\n\n\n14.18 – 14.40\n\n\n\n\n\nRoundtable 3: Implementing UN Global Initiatives and Special Programmes – The Rubber Hitting the Road \n\n\n\n\n\n\n\n\n\n\nModerator: Felipe Roitberg\, WHO Panelists: Lorna Renner (SIOP/Continental President\, Africa)\, Mauricio Maza (PAHO)\, Bishnu Giri (SEARO)\, Elena Ten (Kyrgyzstan Cancer Registry) \n\n\n\n\n\n\n\n14.40 – 14.45\nBrief Break\n\n\n\n  \n\n\n\n14.45 – 15.30\nJoint Session #4: IMPLEMENTATION RESEARCH TO GUIDE PROGRAM SCALE-UP\n\n\n\n\n14.45 – 14.47\n\n\n\n\n\nSession introduction \n\n\n\n\n\n\n\n\n\n\nFacilitator: Andre Ilbawi\, WHO \n\n\n\n\n\n\n\n14.47 – 14.57\n\n\n\n\n\nImplementation research: paving the way for effectiveness \n\n\n\n\n\n\n\n\n\n\nDr Partha Basu\, Deputy Head “Early Detection\, Prevention and Infection” Branch at IARC \n\n\n\n\n\n\n\n14.57 – 15.07\n\n\n\n\nMeasuring impact in country: Priority cancer indicators \n\n\n\n\n\n\n\n\nDr. Alfred Karagu\, National Cancer Institute of Kenya\, CEO \n\n\n\n\n\n\n15.07 – 15.24\n\n\n\n\nDr. Alfred Karagu\, National Cancer Institute of Kenya\, CEO \n\n\n\n\n\n\n\n\n\nModerator: Ben Anderson (WHO)\nPanelist: Julie Gralow (ASCO)\, Nickhill Bhakta (St. Jude)\, Ophira Ginsburg (IARC) \n\n\n\n\n\n\n\n15.24 – 15.28\nQ&A\n\n\n\n\nGroup\, facilitator guided \n\n\n\n\n\n\n15.28 – 15.30\nSUMMARY AND CLOSURE\n\n\n\n\nAndre Ilbawi\, WHO \n\n\n\n\n\n\n\n  \nRead Cancer Control 2021 report
URL:https://www.lgcw.org.uk/event/un-interagency-collaboration-for-effective-global-cancer-controlenabled-by-un-agencies-implemented-by-countries-hosted-by-world-health-organisation-international-agency-for-research-on-cancer-and/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/who-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T170000
DTEND;TZID=Europe/London:20211115T185000
DTSTAMP:20211113T141409Z
CREATED:20210519T193321Z
LAST-MODIFIED:20211113T141409Z
UID:10000050-1636995600-1637002200@www.lgcw.org.uk
SUMMARY:Cancer care - a balance of costs  Hosted by: Royal Society of Medicine Oncology Group
DESCRIPTION:Register \nCancer care – a balance of costs\nSpeakers\nAjay Aggarwal\nDr Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust\, London and Associate Professor at the London School of Hygiene and Tropical Medicine. His main research areas are Health Services Research and Global Health.   \nHe has been the recipient of two fellowship awards from the National Institute for Health Research (NIHR) in 2014 and 2020. In his role as the Oncology Coordinator for the UK National Prostate Cancer Audit\, he co-led the development and delivery of the first ever national hospital outcome reporting programme for radiotherapy.  \nHis research has contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine which has influenced directly the WHO Cancer Drug Pricing and Benefits Taskforces. As co-chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology)\, he is leading the value-based health care initiative and working with the European Commission to support reimbursement policy for medical devices in cancer care. He has previously worked at the World Health Organisation in Geneva\, and has ongoing global health projects in South Africa\, Botswana and Zambia aimed at building radiotherapy capacity and cancer research capability.  \nDr. Dorothy Chilambe Lombe\nDr. Dorothy Chilambe Lombe is a clinical oncologist with sub-specialisation in brachytherapy. She is a Fellow of the College of Radiation Oncologists Colleges of Medicine South Africa\, holds a Master of Medicine degree in Radiation Oncology from Stellenbosch University and primary medical degree from Rostov State Medical University\, Russia.  \nShe has served as Chair of the Cervical Cancer Committee of the National Cancer Technical Working Group in Zambia and is a member of the National Cancer Control Strategic Plan Development Working Group. Internationally is a member of the COVID-19 and Cancer Global Taskforce\, WHO essential medicines list working group for cancer\, ASCO resource and ASCO International Liaisons Program.  \nIn establishing an independent research career she continues to investigate the application of ultrasound based imaging in the radiotherapy process for resource limited environments as well as understanding barriers to quality oncology care. In her spare time she writes a weekly features article on cancer for the local Times of Zambia newspaper and volunteers for the Zambian Cancer Society as part of her advocacy work. \nDr C S Pramesh\nDr C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre\, Mumbai. He serves on the Board of Directors of the Union for International Cancer Control (UICC). He is the convener for the National Cancer Grid\, a large network of 244 cancer centres in India (https://tmc.gov.in/ncg). The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is also a visiting professor at the Division of Cancer Studies\, King’s College London and the Institute of Cancer Policy\, King’s Health Partners\, London. \nHis clinical interests include the management of esophageal and lung cancers. He is the Principal Investigator in several investigator-initiated research studies including randomized trials on cancer screening\, surgical techniques\, neoadjuvant and adjuvant treatment of thoracic cancers. His broader research interests include cancer policy\, health equity\, value-based care and health services research. He has more than 200 peer-reviewed journal articles\, abstracts and book chapters on various topics including thoracic oncology\, clinical research methods\, translational research\, health equity\, and cancer policy. \nProf Pramesh has strong interests in clinical trial designs\, surgical trials\, comparative effectiveness research\, promoting collaborative research and cancer policy. He is a Post-Graduate Diplomate in Clinical Trials from the London School of Hygiene and Tropical Medicine\, University of London. He is keen on promoting training in clinical research methods and conducts several courses on clinical research methodology\, biostatistics and scientific writing. He serves on the advisory boards of several national and international research organizations and granting agencies. \n  \n  \n 
URL:https://www.lgcw.org.uk/event/cancer-control-in-low-and-middle-income-countries-hosted-by-royal-society-of-medicine-oncology-group/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/RSM-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211115T190000
DTEND;TZID=Europe/London:20211115T200000
DTSTAMP:20220320T122828Z
CREATED:20211026T083606Z
LAST-MODIFIED:20220320T122828Z
UID:10000064-1637002800-1637006400@www.lgcw.org.uk
SUMMARY:Cancer after Covid: building a more resilient system for the future  This session has been sponsored by Roche Products Limited
DESCRIPTION:Watch the Event Again \nCancer after Covid: building a more resilient system for the future\nThis session is both a face to face and virtual event. If you would like to join in person\, please click on the in person event link. \nEven before the pandemic\, health systems around the world were under significant pressure. Now\, we’re facing even greater challenges with a backlog of undiagnosed and untreated cancer cases. \nJoin Roche and a distinguished group of experts to discuss pragmatic solutions and to explore how advances made to stop COVID-19 could also make a real difference for cancer patients and be used to build stronger\, more resilient cancer services for the future. \nTime:  6:30 – 9:00 p.m. Location: Royal College of Physicians\, 11 St Andrews Place\, Regent’s Park\, London NW1 4LE \nGuests are welcome to arrive at 6:30 p.m. for networking and the panel session will begin at 7:00 p.m. \nThis session has been funded by Roche
URL:https://www.lgcw.org.uk/event/cancer-after-covid-building-a-more-resilient-system-for-the-future-this-session-has-been-sponsored-by-roche-products-limited/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/10/roche-logo.png
END:VEVENT
END:VCALENDAR